These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35837891)

  • 1. Magnetic Resonance Imaging Directed Surgical Decision Making for Lateral Pelvic Lymph Node Dissection in Rectal Cancer After Total Neoadjuvant Therapy (TNT).
    Peacock O; Manisundaram N; Dibrito SR; Kim Y; Hu CY; Bednarski BK; Konishi T; Stanietzky N; Vikram R; Kaur H; Taggart MW; Dasari A; Holliday EB; You YN; Chang GJ
    Ann Surg; 2022 Oct; 276(4):654-664. PubMed ID: 35837891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy.
    Ogura A; Akiyoshi T; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Kuroyanagi H
    World J Surg; 2017 Mar; 41(3):868-875. PubMed ID: 27730352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robotic lateral pelvic lymph node dissection after chemoradiation for rectal cancer: a Western perspective.
    Peacock O; Limvorapitak T; Bednarski BK; Kaur H; Taggart MW; Dasari A; Holliday EB; Minsky BD; You YN; Chang GJ
    Colorectal Dis; 2020 Dec; 22(12):2049-2056. PubMed ID: 32892473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer.
    Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does adding lateral pelvic lymph node dissection to neoadjuvant chemotherapy improve outcomes in low rectal cancer?
    Law BZY; Yusuf Z; Ng YE; Aly EH
    Int J Colorectal Dis; 2020 Aug; 35(8):1387-1395. PubMed ID: 32504333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between preoperative chemoradiotherapy and lateral pelvic lymph node dissection in clinical T3 low rectal cancer without enlarged lateral lymph nodes.
    Tsukada Y; Rullier E; Shiraishi T; Capdepont M; Sasaki T; Celerier B; Denost Q; Ito M
    Colorectal Dis; 2023 Jun; 25(6):1153-1162. PubMed ID: 36932710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomics Approach Outperforms Diameter Criteria for Predicting Pathological Lateral Lymph Node Metastasis After Neoadjuvant (Chemo)Radiotherapy in Advanced Low Rectal Cancer.
    Nakanishi R; Akiyoshi T; Toda S; Murakami Y; Taguchi S; Oba K; Hanaoka Y; Nagasaki T; Yamaguchi T; Konishi T; Matoba S; Ueno M; Fukunaga Y; Kuroyanagi H
    Ann Surg Oncol; 2020 Oct; 27(11):4273-4283. PubMed ID: 32767224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lateral pelvic lymph node dissection in the management of locally advanced low rectal cancer: Summary of the current evidence.
    Elhusseini M; Aly EH
    Surg Oncol; 2020 Dec; 35():418-425. PubMed ID: 33038847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional outcomes after lateral pelvic lymph node dissection for rectal cancer: a systematic review and meta-analysis.
    Cribb BI; Kong J; McCormick J; Warrier SK; Heriot AG
    Int J Colorectal Dis; 2022 Mar; 37(3):583-595. PubMed ID: 34846550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of indocyanine green fluorescence imaging-guided laparoscopic lateral pelvic lymph node dissection for clinical stage II/III middle-lower rectal cancer: a propensity score-matched cohort study.
    Watanabe J; Ohya H; Sakai J; Suwa Y; Goto K; Nakagawa K; Ozawa M; Ishibe A; Suwa H; Kunisaki C; Endo I
    Tech Coloproctol; 2023 Sep; 27(9):759-767. PubMed ID: 36773172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patterns.
    Yamamoto T; Kawada K; Hida K; Ganeko R; Inamoto S; Yoshitomi M; Watanabe T; Sakai Y
    Int J Clin Oncol; 2019 Jun; 24(6):677-685. PubMed ID: 30721379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic treatment of rectal cancer and lateral pelvic lymph node dissection: are they obsolete?
    Toda S; Kuroyanagi H; Matoba S; Hiramatsu K; Okazaki N; Tate T; Tomizawa K; Hanaoka Y; Moriyama J
    Minerva Chir; 2018 Dec; 73(6):558-573. PubMed ID: 29795062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?
    Malakorn S; Yang Y; Bednarski BK; Kaur H; You YN; Holliday EB; Dasari A; Skibber JM; Rodriguez-Bigas MA; Chang GJ
    Dis Colon Rectum; 2019 Oct; 62(10):1158-1166. PubMed ID: 31490825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically enlarged lateral pelvic lymph nodes do not influence prognosis after neoadjuvant therapy and TME in stage III rectal cancer.
    Dharmarajan S; Shuai D; Fajardo AD; Birnbaum EH; Hunt SR; Mutch MG; Fleshman JW; Lin AY
    J Gastrointest Surg; 2011 Aug; 15(8):1368-74. PubMed ID: 21533959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting lateral pelvic lymph node metastasis based on magnetic resonance imaging before and after neoadjuvant chemotherapy for patients with locally advanced lower rectal cancer.
    Sekido Y; Nishimura J; Fujino S; Ogino T; Miyoshi N; Takahashi H; Uemura M; Haraguchi N; Hata T; Matsuda C; Mizushima T; Murata K; Hasegawa J; Mori M; Doki Y
    Surg Today; 2020 Mar; 50(3):292-297. PubMed ID: 31595366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncological Outcomes of Patients with Locally Advanced Rectal Cancer and Lateral Pelvic Lymph Node Involvement.
    Sapci I; Delaney CP; Liska D; Amarnath S; Kalady MF; Steele SR; Gorgun E
    J Gastrointest Surg; 2019 Jul; 23(7):1454-1460. PubMed ID: 31012043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
    Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
    Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of laparoscopic lateral pelvic lymph node dissection on urinary retention in rectal cancer.
    Sadakari Y; Hisano K; Sada M; Mizuuchi Y; Nagayoshi K; Fujita H; Nagai S; Manabe T; Ueki T; Nakamura M
    Surg Endosc; 2022 Feb; 36(2):999-1007. PubMed ID: 33616731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lateral pelvic lymph node dissection can be omitted in lower rectal cancer in which the longest lateral pelvic and perirectal lymph node is less than 5 mm on MRI.
    Ogawa S; Itabashi M; Hirosawa T; Hashimoto T; Bamba Y; Kameoka S
    J Surg Oncol; 2014 Mar; 109(3):227-33. PubMed ID: 24165955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The important risk factor for lateral pelvic lymph node metastasis of lower rectal cancer is node-positive status on magnetic resonance imaging: study of the Lymph Node Committee of Japanese Society for Cancer of the Colon and Rectum.
    Ogawa S; Hida J; Ike H; Kinugasa T; Ota M; Shinto E; Itabashi M; Okamoto T; Sugihara K
    Int J Colorectal Dis; 2016 Oct; 31(10):1719-28. PubMed ID: 27576475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.